According to a new, phase 2 clinical trial led by Dana-Farber Cancer Institute doctors, a three-medicine combination that drove chronic lymphocytic leukaemia (CLL) patients into profound remissions in a clinical study is very beneficial in patients with high-risk variants of the disease.
Beijing [China], March 8 (ANI): A recent internal document from the Chinese National Health Commission (NHC) showed that the (Chinese) COVID-19 vaccines had caused leukaemia, local media reported.